title: Current and future treatment modalities for hepatocellular carcinoma.
abstract: This article reviews recent innovations in the treatment of Hepatocellular carcinoma (HCC), which, although a common malignancy, has often proved difficult to diagnose and treat effectively. The epidemiology and natural history of HCC are discussed, as well as treatments such as hepatic resection, liver transplantation, and cryosurgery, among others.
authors.affiliation: Dumont-UCLA Liver Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, University of California, Los Angeles 90024-1749, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Farmer
authors.forename: P
authors.initials: P
authors.lastname: Seu
authors.forename: K
authors.initials: K
authors.lastname: Swenson
authors.forename: J
authors.initials: J
authors.lastname: Economou
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000639:trends; D003131:Combined Modality Therapy / Q000639:trends; D013505:Digestive System Surgical Procedures / Q000639:trends; D000431:Ethanol / Q000008:administration & dosage; D015316:Genetic Therapy / Q000639:trends; D006801:Humans; D006979:Hyperthermia, Induced / Q000639:trends; D007167:Immunotherapy / Q000639:trends; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000628:therapy*; D012997:Solvents / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D012997:Solvents; D000431:Ethanol